English
简体中文
繁體中文
English
Filipino
हिन्दी
Hmong
Bahasa Indonesia
日本語
Basa Jawa
한국어
ພາສາລາວ
Bahasa Melayu
മലയാളം
ဗမာစာ
سنڌي
தமிழ்
ไทย
Tiếng Việt
Afrikaans
Shqip
العربية
አማርኛ
Հայերեն
Azərbaycan dili
Euskara
Беларуская мова
বাংলা
Bosanski
Български
Català
Cebuano
Chichewa
Corsu
Italiano
Hrvatski
Čeština
Dansk
Nederlands
Esperanto
Eesti
Suomi
Frysk
Galego
ქართული
Ελληνικά
ગુજરાતી
Kreyol ayisyen
Deutsch
Français
Harshen Hausa
Ōlelo Hawaiʻi
עִבְרִית
Magyar
Íslenska
Igbo
Gaeilge
ಕನ್ನಡ
Қазақ тілі
ភាសាខ្មែរ
كوردی
Кыргызча
Latin
Latviešu valoda
Lietuvių kalba
Lëtzebuergesch
Македонски јазик
Malagasy
Maltese
Te Reo Māori
मराठी
Монгол
नेपाली
Norsk bokmål
پښتو
فارسی
Polski
Português
ਪੰਜਾਬੀ
Română
Русский
Samoan
Gàidhlig
Српски језик
Sesotho
Shona
සිංහල
Slovenčina
Slovenščina
Afsoomaali
Español
Basa Sunda
Kiswahili
Svenska
Тоҷикӣ
తెలుగు
Türkçe
Українська
اردو
O‘zbekcha
Cymraeg
isiXhosa
יידיש
Yorùbá
ZuluLaboratory Operations Suspended as COVID Testing Demand Wanes
Q&M Dental Group has made the strategic decision to suspend operations at its Acumen laboratory facility, following the expiration of its laboratory licence on September 15th. This significant move comes in response to sustained financial challenges, with Acumen experiencing continuous losses throughout 2023 and into the first half of 2024, primarily attributed to diminishing demand for COVID-19 PCR testing services.
Strategic Reallocation of Resources
The dental healthcare provider has indicated plans to strategically redirect resources from these operations. The group intends to channel potential cost savings towards the development of new diagnostics-related ventures within Acumen’s existing portfolio, demonstrating a forward-looking approach to evolving market conditions.
Closure of Sengkang Testing and Vaccination Centre
In a related development, the company has announced the forthcoming closure of its joint testing and vaccination centre in Sengkang. This closure, scheduled for 1 December, comes in accordance with directives from the Ministry of Health (MOH), marking the end of another chapter in Singapore’s COVID-19 response infrastructure.
Future Outlook and Business Continuity
While the suspension of Acumen’s testing operations will impact the group’s revenue stream, Q&M has maintained an optimistic outlook for future opportunities. The company has expressed its intention to actively pursue new MOH contract opportunities, leaving the door open for potential re-entry into clinical testing services. The group has specifically indicated its willingness to consider reapplying for a laboratory licence in the future, suggesting a flexible approach to market conditions and regulatory requirements.
The restructuring represents a significant pivot in Q&M’s operational strategy, reflecting broader changes in Singapore’s healthcare landscape as the country continues to adapt to post-pandemic healthcare needs.
The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.
Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.
The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.